Craft

BioPerfectus

Stock Price

¥77.8

2024-10-29

Market Capitalization

¥4.4 B

2024-10-29

Revenue

¥324.6 M

FY, 2024

BioPerfectus Summary

Company Summary

Overview
BioPerfectus (also known as Jiangsu Bioperfectus Technologies, 江苏硕世生物科技股份有限公司) is a company focused on nucleic acid extraction systems, PCR-based assays, and related consumables. Its portfolio includes automated nucleic acid extraction devices, multiplex real-time PCR and digital PCR kits, and solutions for women’s health, such as quantitative HPV genotyping for cervical cancer screening, along with infectious disease panels including respiratory, vector-borne, and bloodborne pathogens. The company also offers ELISA and lateral flow products, laboratory workflow solutions, and raw material components such as enzymes and antibodies.
Type
Public
Status
Active
Founded
2010
HQ
Taizhou, CN | view all locations
Website
https://www.bioperfectus.com/
Cybersecurity rating
Sectors

Key People

  • Guoqiang Wang

    Guoqiang Wang, Chairman & CEO

    • Yuanyuan Meng, Financial Director

      • Zhonghua Liu, Non-Independent Director

        • Joseph Chow

        LocationsView all

        4 locations detected

        • Taizhou, Jiang Su Sheng HQ

          China

          No. 837 Yaocheng Avenue

        • Natick, MA

          United States

          12 Michigan Dr

        • Shanghai, Shang Hai Shi

          China

          2nd Floor, Block 10, No.188 Xinjun Ring Road, Pujiang High-Tech Park, Caohejing Development Area

        • Belfast, Northern Ireland

          United Kingdom

          ASM Belfast, 4th Floor, Glendinning House, 6 Murray St

        BioPerfectus Financials

        Summary Financials

        Revenue (Q1, 2026)
        ¥76.8M
        Gross profit (Q1, 2026)
        ¥44.4M
        Net income (Q1, 2026)
        ¥21.1M
        Cash (Q1, 2026)
        ¥477.4M
        EBIT (Q1, 2026)
        ¥27.2M
        Enterprise value
        $4.4B

        Footer menu